GWM
REGN icon

Greenwich Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Greenwich Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4M Sell
16,102
-19
-0.1% -$14.5K 0.51% 35
2025
Q4 		$12.4M Sell
16,121
-40
-0.2% -$27.2K 0.56% 34
2025
Q3 		$9.09M Buy
16,161
+7
+0% +$3.96K 0.45% 33
2025
Q2 		$8.48M Buy
16,154
+14
+0.1% +$7.81K 0.41% 33
2025
Q1 		$10.2M Buy
16,140
+59
+0.4% +$40.6K 0.77% 20
2024
Q4 		$11.5M Buy
16,081
+14
+0.1% +$11.7K 0.81% 19
2024
Q3 		$16.9M Sell
16,067
-12
-0.1% -$13.4K 1.15% 10
2024
Q2 		$16.9M Sell
16,079
-1
-0% -$969 1.23% 10
2024
Q1 		$15.5M Buy
16,080
+5
+0% +$4.75K 1.23% 12
2023
Q4 		$14.1M Sell
16,075
-20
-0.1% -$16.5K 1.39% 11
2023
Q3 		$13.2M Buy
16,095
+24
+0.1% +$18.9K 1.4% 9
2023
Q2 		$11.5M Sell
16,071
-34
-0.2% -$26.2K 1.21% 12
2023
Q1 		$13.2M Sell
16,105
-7
-0% -$5.28K 1.44% 11
2022
Q4 		$11.6M Sell
16,112
-39
-0.2% -$28.8K 1.28% 13
2022
Q3 		$11.1M Buy
16,151
+12
+0.1% +$7.55K 1.19% 12
2022
Q2 		$9.54M Sell
16,139
-25
-0.2% -$16.3K 1.26% 13
2022
Q1 		$11.3M Hold
16,164
– – 1.15% 12
2021
Q4 		$10.2M Sell
16,164
-13
-0.1% -$7.99K 0.83% 13
2021
Q3 		$9.79M Sell
16,177
-61
-0.4% -$37.9K 0.81% 13
2021
Q2 		$9.07M Buy
16,238
+59
+0.4% +$29.9K 0.77% 15
2021
Q1 		$7.66M Buy
16,179
+50
+0.3% +$24.3K 0.61% 16
2020
Q4 		$7.79M Buy
16,129
+62
+0.4% +$33.5K 0.68% 16
2020
Q3 		$8.99M Buy
16,067
+2
+0% +$1.21K 1.61% 14
2020
Q2 		$10M Sell
16,065
-100
-0.6% -$56.8K 1.92% 13
2020
Q1 		$7.89M Buy
+16,165
New +$6.67M 1.69% 13

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Greenwich Wealth Management's REGN Position: Q1 2026 in Review

Greenwich Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 0.12% in Q1 2026, selling an estimated $14.5K and leaving 16,102 shares worth $12.4M. The position accounts for 0.51% of the portfolio, ranked #35.

Greenwich Wealth Management first reported a position in REGN in Q1 2020 and has held it in 25 quarters since. The position peaked at $16.9M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Greenwich Wealth Management held 16,102 shares of Regeneron Pharmaceuticals worth $12.4M as of Q1 2026.
  • Greenwich Wealth Management sold 19 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $14.5K.
  • Regeneron Pharmaceuticals made up 0.51% of Greenwich Wealth Management's portfolio in Q1 2026, its #35 holding.
  • Greenwich Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
  • Greenwich Wealth Management's Regeneron Pharmaceuticals position peaked at $16.9M in Q2 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.